These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 24768876)

  • 1. Implications of coronary artery disease in heart failure with preserved ejection fraction.
    Hwang SJ; Melenovsky V; Borlaug BA
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction.
    Rusinaru D; Houpe D; Szymanski C; Lévy F; Maréchaux S; Tribouilloy C
    Eur J Heart Fail; 2014 Sep; 16(9):967-76. PubMed ID: 25111982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach.
    Trevisan L; Cautela J; Resseguier N; Laine M; Arques S; Pinto J; Orabona M; Barraud J; Peyrol M; Paganelli F; Bonello L; Thuny F
    Arch Cardiovasc Dis; 2018 Feb; 111(2):109-118. PubMed ID: 29031580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study.
    John JE; Claggett B; Skali H; Solomon SD; Cunningham JW; Matsushita K; Konety SH; Kitzman DW; Mosley TH; Clark D; Chang PP; Shah AM
    J Am Heart Assoc; 2022 Sep; 11(17):e021660. PubMed ID: 36000416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of coronary CT angiography in heart failure patients with preserved ejection fraction.
    Yu MM; Zuo WX; Zhao X; Tang XL; Chen YY; Dong LL; Shu XH; Jin H; Zeng MS
    Eur Radiol; 2023 May; 33(5):3052-3063. PubMed ID: 36629927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).
    Mentz RJ; Broderick S; Shaw LK; Fiuzat M; O'Connor CM
    J Am Coll Cardiol; 2014 Jan; 63(3):251-8. PubMed ID: 24161322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization for Patients With Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease.
    Fu M; Wang Y; Han X; Yuan S; Liu Y; Qian J; Zhou J; Ge J
    Am J Cardiol; 2024 Feb; 213():86-92. PubMed ID: 38199145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
    Badar AA; Perez-Moreno AC; Hawkins NM; Jhund PS; Brunton AP; Anand IS; McKelvie RS; Komajda M; Zile MR; Carson PE; Gardner RS; Petrie MC; McMurray JJ
    Circ Heart Fail; 2015 Jul; 8(4):717-24. PubMed ID: 26067854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease].
    Chai K; Wang H; Li YY; Luo Y; Fang F; Liu DG; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):710-715. PubMed ID: 28851190
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 17. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
    Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular long-axis performance during exercise is an important prognosticator in patients with heart failure and preserved ejection fraction.
    Wang J; Fang F; Wai-Kwok Yip G; Sanderson JE; Feng W; Xie JM; Luo XX; Lee AP; Lam YY
    Int J Cardiol; 2015 Jan; 178():131-5. PubMed ID: 25464236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.